| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Notch binding | 4.97e-06 | 27 | 25 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 4.67e-05 | 547 | 25 | 6 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 5.01e-05 | 554 | 25 | 6 | GO:0030546 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 9.03e-05 | 616 | 25 | 6 | GO:0030545 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 9.86e-05 | 12 | 25 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.62e-04 | 749 | 25 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 3.75e-04 | 23 | 25 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 5.98e-04 | 29 | 25 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 6.04e-04 | 1233 | 25 | 7 | GO:0140677 | |
| GeneOntologyMolecularFunction | growth factor activity | 1.28e-03 | 173 | 25 | 3 | GO:0008083 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.62e-03 | 188 | 25 | 3 | GO:0005201 | |
| GeneOntologyBiologicalProcess | regulation of cell development | TLE6 GRN TNFRSF1B DLL1 MEGF8 SEMA7A DCT PLXNB2 PLXNB3 JAG1 PROC | 2.01e-08 | 1095 | 25 | 11 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.69e-08 | 625 | 25 | 9 | GO:0051960 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TLE6 HGF PLA2G5 TNFRSF1B MEGF8 SEMA7A DCT PLXNB2 PLXNB3 JAG1 PROC | 3.08e-08 | 1141 | 25 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.06e-07 | 515 | 25 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | LAMA5 HGF GRN PLD1 MEGF8 SEMA7A SEMA5B PLXNB2 ANO6 PLXNB3 JAG1 | 1.44e-07 | 1327 | 25 | 11 | GO:0040012 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.52e-07 | 354 | 25 | 7 | GO:0050769 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 4.07e-07 | 614 | 25 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 4.37e-07 | 52 | 25 | 4 | GO:0071526 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 4.68e-07 | 418 | 25 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 6.81e-07 | 1211 | 25 | 10 | GO:0030334 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 1.13e-06 | 1280 | 25 | 10 | GO:2000145 | |
| GeneOntologyBiologicalProcess | chemotaxis | 1.94e-06 | 517 | 25 | 7 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 1.99e-06 | 519 | 25 | 7 | GO:0042330 | |
| GeneOntologyBiologicalProcess | neural crest cell development | 3.82e-06 | 89 | 25 | 4 | GO:0014032 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 5.85e-06 | 99 | 25 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | stem cell development | 6.33e-06 | 101 | 25 | 4 | GO:0048864 | |
| GeneOntologyBiologicalProcess | neural crest cell differentiation | 7.11e-06 | 104 | 25 | 4 | GO:0014033 | |
| GeneOntologyBiologicalProcess | axon development | 8.07e-06 | 642 | 25 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 8.81e-06 | 239 | 25 | 5 | GO:0050728 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 8.82e-06 | 927 | 25 | 8 | GO:0030155 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.02e-05 | 114 | 25 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 1.85e-05 | 1366 | 25 | 9 | GO:0051130 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 2.07e-05 | 742 | 25 | 7 | GO:0040017 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 2.11e-05 | 6 | 25 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 2.20e-05 | 494 | 25 | 6 | GO:0031346 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 2.47e-05 | 296 | 25 | 5 | GO:0048762 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response | 2.78e-05 | 515 | 25 | 6 | GO:0050727 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 2.86e-05 | 1090 | 25 | 8 | GO:0022603 | |
| GeneOntologyBiologicalProcess | axonogenesis | 4.72e-05 | 566 | 25 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 4.79e-05 | 846 | 25 | 7 | GO:0120035 | |
| GeneOntologyBiologicalProcess | immune effector process | 5.28e-05 | 859 | 25 | 7 | GO:0002252 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 5.43e-05 | 863 | 25 | 7 | GO:0031344 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 5.67e-05 | 62 | 25 | 3 | GO:0001755 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | 5.72e-05 | 353 | 25 | 5 | GO:0031348 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 6.24e-05 | 64 | 25 | 3 | GO:0090497 | |
| GeneOntologyBiologicalProcess | loop of Henle development | 6.31e-05 | 10 | 25 | 2 | GO:0072070 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 7.28e-05 | 612 | 25 | 6 | GO:0010975 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 7.33e-05 | 372 | 25 | 5 | GO:0060485 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 7.61e-05 | 375 | 25 | 5 | GO:0007162 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 7.76e-05 | 619 | 25 | 6 | GO:0002009 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 7.90e-05 | 192 | 25 | 4 | GO:0050770 | |
| GeneOntologyBiologicalProcess | neuron projection development | 9.24e-05 | 1285 | 25 | 8 | GO:0031175 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 1.09e-04 | 1316 | 25 | 8 | GO:0032101 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 1.42e-04 | 691 | 25 | 6 | GO:0030335 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 1.47e-04 | 15 | 25 | 2 | GO:0048505 | |
| GeneOntologyBiologicalProcess | inflammatory response | 1.78e-04 | 1043 | 25 | 7 | GO:0006954 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 1.85e-04 | 725 | 25 | 6 | GO:2000147 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 1.90e-04 | 17 | 25 | 2 | GO:0040034 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection regeneration | 2.13e-04 | 18 | 25 | 2 | GO:0070572 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 2.15e-04 | 249 | 25 | 4 | GO:0010976 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 2.19e-04 | 748 | 25 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 2.22e-04 | 750 | 25 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | neuron development | 2.28e-04 | 1463 | 25 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | negative regulation of neuroinflammatory response | 2.64e-04 | 20 | 25 | 2 | GO:0150079 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 2.84e-04 | 497 | 25 | 5 | GO:0002697 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.84e-04 | 1125 | 25 | 7 | GO:0035239 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 3.12e-04 | 110 | 25 | 3 | GO:0072080 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 3.17e-04 | 509 | 25 | 5 | GO:0032102 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 3.18e-04 | 802 | 25 | 6 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 3.56e-04 | 819 | 25 | 6 | GO:0120039 | |
| GeneOntologyBiologicalProcess | axon guidance | 3.59e-04 | 285 | 25 | 4 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.64e-04 | 286 | 25 | 4 | GO:0097485 | |
| GeneOntologyBiologicalProcess | renal tubule development | 3.64e-04 | 116 | 25 | 3 | GO:0061326 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 3.73e-04 | 826 | 25 | 6 | GO:0048858 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 3.83e-04 | 24 | 25 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 4.09e-04 | 1194 | 25 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 4.70e-04 | 306 | 25 | 4 | GO:0048863 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 4.86e-04 | 128 | 25 | 3 | GO:0072009 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 5.23e-04 | 28 | 25 | 2 | GO:0060445 | |
| GeneOntologyBiologicalProcess | positive regulation of myelination | 5.61e-04 | 29 | 25 | 2 | GO:0031643 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell proliferation | 5.61e-04 | 29 | 25 | 2 | GO:0014856 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 5.62e-04 | 577 | 25 | 5 | GO:0001667 | |
| GeneOntologyBiologicalProcess | axon extension | 5.68e-04 | 135 | 25 | 3 | GO:0048675 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 5.80e-04 | 136 | 25 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | 6.87e-04 | 603 | 25 | 5 | GO:0050673 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle tissue development | 7.28e-04 | 33 | 25 | 2 | GO:0048641 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 8.96e-04 | 158 | 25 | 3 | GO:0045446 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 9.63e-04 | 162 | 25 | 3 | GO:0072073 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 9.65e-04 | 38 | 25 | 2 | GO:0007435 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 9.81e-04 | 163 | 25 | 3 | GO:0002456 | |
| GeneOntologyBiologicalProcess | regulation of defense response | 1.06e-03 | 1006 | 25 | 6 | GO:0031347 | |
| GeneOntologyBiologicalProcess | tube development | 1.07e-03 | 1402 | 25 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 1.18e-03 | 42 | 25 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | nephron development | 1.18e-03 | 174 | 25 | 3 | GO:0072006 | |
| GeneOntologyBiologicalProcess | myoblast proliferation | 1.24e-03 | 43 | 25 | 2 | GO:0051450 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 1.24e-03 | 43 | 25 | 2 | GO:0001953 | |
| GeneOntologyBiologicalProcess | salivary gland development | 1.24e-03 | 43 | 25 | 2 | GO:0007431 | |
| GeneOntologyBiologicalProcess | embryo development | 1.24e-03 | 1437 | 25 | 7 | GO:0009790 | |
| GeneOntologyBiologicalProcess | endothelium development | 1.35e-03 | 182 | 25 | 3 | GO:0003158 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.40e-03 | 410 | 25 | 4 | GO:0031589 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.69e-07 | 530 | 26 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.54e-07 | 656 | 26 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.73e-07 | 658 | 26 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.15e-04 | 13 | 26 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | specific granule membrane | 1.93e-04 | 91 | 26 | 3 | GO:0035579 | |
| GeneOntologyCellularComponent | cholinergic synapse | 3.38e-04 | 22 | 26 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | basement membrane | 4.57e-04 | 122 | 26 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | secretory granule membrane | 6.85e-04 | 329 | 26 | 4 | GO:0030667 | |
| GeneOntologyCellularComponent | specific granule | 1.01e-03 | 160 | 26 | 3 | GO:0042581 | |
| GeneOntologyCellularComponent | secretory granule | 1.28e-03 | 1014 | 26 | 6 | GO:0030141 | |
| GeneOntologyCellularComponent | cell surface | 2.04e-03 | 1111 | 26 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.90e-03 | 487 | 26 | 4 | GO:0016324 | |
| GeneOntologyCellularComponent | secretory vesicle | 3.64e-03 | 1246 | 26 | 6 | GO:0099503 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 3.70e-03 | 73 | 26 | 2 | GO:0070821 | |
| GeneOntologyCellularComponent | receptor complex | 5.43e-03 | 581 | 26 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | apical part of cell | 5.80e-03 | 592 | 26 | 4 | GO:0045177 | |
| GeneOntologyCellularComponent | Golgi lumen | 8.07e-03 | 109 | 26 | 2 | GO:0005796 | |
| Domain | EGF_1 | 3.65e-11 | 255 | 26 | 9 | PS00022 | |
| Domain | EGF-like_CS | 4.50e-11 | 261 | 26 | 9 | IPR013032 | |
| Domain | EGF_2 | 5.15e-11 | 265 | 26 | 9 | PS01186 | |
| Domain | Plexin_repeat | 6.82e-10 | 32 | 26 | 5 | IPR002165 | |
| Domain | PSI | 6.82e-10 | 32 | 26 | 5 | PF01437 | |
| Domain | EGF | 7.17e-10 | 235 | 26 | 8 | SM00181 | |
| Domain | EGF-like_dom | 1.13e-09 | 249 | 26 | 8 | IPR000742 | |
| Domain | PSI | 3.64e-09 | 44 | 26 | 5 | IPR016201 | |
| Domain | PSI | 4.58e-09 | 46 | 26 | 5 | SM00423 | |
| Domain | EGF_3 | 2.45e-08 | 235 | 26 | 7 | PS50026 | |
| Domain | SEMA | 9.05e-08 | 31 | 26 | 4 | PS51004 | |
| Domain | Sema | 9.05e-08 | 31 | 26 | 4 | SM00630 | |
| Domain | Semap_dom | 9.05e-08 | 31 | 26 | 4 | IPR001627 | |
| Domain | Sema | 9.05e-08 | 31 | 26 | 4 | PF01403 | |
| Domain | Laminin_EGF | 1.50e-07 | 35 | 26 | 4 | PF00053 | |
| Domain | EGF_Lam | 1.50e-07 | 35 | 26 | 4 | SM00180 | |
| Domain | Laminin_EGF | 2.11e-07 | 38 | 26 | 4 | IPR002049 | |
| Domain | EGF_CA | 6.45e-07 | 122 | 26 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.00e-07 | 124 | 26 | 5 | IPR001881 | |
| Domain | EGF | 7.58e-07 | 126 | 26 | 5 | PF00008 | |
| Domain | hEGF | 7.67e-06 | 28 | 26 | 3 | PF12661 | |
| Domain | EGF_Ca-bd_CS | 9.36e-06 | 97 | 26 | 4 | IPR018097 | |
| Domain | EGF_LAM_2 | 9.48e-06 | 30 | 26 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 9.48e-06 | 30 | 26 | 3 | PS01248 | |
| Domain | EGF_CA | 1.02e-05 | 99 | 26 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.06e-05 | 100 | 26 | 4 | PS00010 | |
| Domain | DSL | 1.12e-05 | 4 | 26 | 2 | PF01414 | |
| Domain | DSL | 1.12e-05 | 4 | 26 | 2 | SM00051 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.33e-05 | 106 | 26 | 4 | IPR000152 | |
| Domain | DSL | 1.86e-05 | 5 | 26 | 2 | IPR001774 | |
| Domain | DSL | 1.86e-05 | 5 | 26 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 1.86e-05 | 5 | 26 | 2 | IPR011651 | |
| Domain | MNNL | 1.86e-05 | 5 | 26 | 2 | PF07657 | |
| Domain | Growth_fac_rcpt_ | 6.07e-05 | 156 | 26 | 4 | IPR009030 | |
| Domain | Plexin_cytopl | 6.67e-05 | 9 | 26 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 6.67e-05 | 9 | 26 | 2 | IPR013548 | |
| Domain | Plexin | 6.67e-05 | 9 | 26 | 2 | IPR031148 | |
| Domain | - | 8.45e-05 | 333 | 26 | 5 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 8.69e-05 | 335 | 26 | 5 | IPR015943 | |
| Domain | LAMININ_NTER | 2.21e-04 | 16 | 26 | 2 | PS51117 | |
| Domain | Laminin_N | 2.21e-04 | 16 | 26 | 2 | PF00055 | |
| Domain | EMI_domain | 2.21e-04 | 16 | 26 | 2 | IPR011489 | |
| Domain | Laminin_N | 2.21e-04 | 16 | 26 | 2 | IPR008211 | |
| Domain | LamNT | 2.21e-04 | 16 | 26 | 2 | SM00136 | |
| Domain | EMI | 2.50e-04 | 17 | 26 | 2 | PS51041 | |
| Domain | Semaphorin | 3.49e-04 | 20 | 26 | 2 | IPR027231 | |
| Domain | IPT | 6.40e-04 | 27 | 26 | 2 | SM00429 | |
| Domain | TIG | 8.45e-04 | 31 | 26 | 2 | PF01833 | |
| Domain | IPT | 9.01e-04 | 32 | 26 | 2 | IPR002909 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 9.58e-04 | 33 | 26 | 2 | IPR001368 | |
| Domain | EGF_extracell | 3.14e-03 | 60 | 26 | 2 | IPR013111 | |
| Domain | EGF_2 | 3.14e-03 | 60 | 26 | 2 | PF07974 | |
| Domain | TSP_1 | 3.45e-03 | 63 | 26 | 2 | PF00090 | |
| Domain | TSP1 | 3.67e-03 | 65 | 26 | 2 | SM00209 | |
| Domain | TSP1_rpt | 3.67e-03 | 65 | 26 | 2 | IPR000884 | |
| Domain | TSP1 | 3.67e-03 | 65 | 26 | 2 | PS50092 | |
| Domain | EGF_CA | 6.34e-03 | 86 | 26 | 2 | PF07645 | |
| Domain | Rho_GTPase_activation_prot | 6.63e-03 | 88 | 26 | 2 | IPR008936 | |
| Pathway | KEGG_AXON_GUIDANCE | 4.31e-05 | 129 | 22 | 4 | M5539 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 4.86e-05 | 7 | 22 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 8.31e-05 | 9 | 22 | 2 | M47866 | |
| Pathway | WP_CANCER_PATHWAYS | 9.59e-05 | 507 | 22 | 6 | M48302 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.55e-04 | 68 | 22 | 3 | M27303 | |
| Pathway | REACTOME_NEPHRON_DEVELOPMENT | 1.79e-04 | 13 | 22 | 2 | M48245 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.79e-04 | 13 | 22 | 2 | M47423 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 2.09e-04 | 14 | 22 | 2 | MM15047 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.41e-04 | 15 | 22 | 2 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.75e-04 | 16 | 22 | 2 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 3.12e-04 | 17 | 22 | 2 | M39389 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.91e-04 | 19 | 22 | 2 | M10959 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.91e-04 | 19 | 22 | 2 | MM15594 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 5.27e-04 | 22 | 22 | 2 | M27210 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.22e-04 | 109 | 22 | 3 | MM15164 | |
| Pathway | REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 6.56e-04 | 111 | 22 | 3 | M27609 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.56e-04 | 111 | 22 | 3 | M27416 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 6.82e-04 | 25 | 22 | 2 | M27879 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 7.16e-04 | 478 | 22 | 5 | M27620 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.97e-04 | 27 | 22 | 2 | M39545 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.85e-04 | 30 | 22 | 2 | M27772 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.85e-04 | 30 | 22 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.85e-04 | 30 | 22 | 2 | MM15812 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.05e-03 | 31 | 22 | 2 | M592 | |
| Pathway | KEGG_ETHER_LIPID_METABOLISM | 1.19e-03 | 33 | 22 | 2 | M2130 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.19e-03 | 33 | 22 | 2 | M604 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.37e-03 | 143 | 22 | 3 | M27275 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.46e-03 | 325 | 22 | 4 | M12868 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.66e-03 | 39 | 22 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.66e-03 | 39 | 22 | 2 | MM15165 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.66e-03 | 39 | 22 | 2 | MM14604 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 1.66e-03 | 39 | 22 | 2 | M653 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.84e-03 | 41 | 22 | 2 | M27778 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.21e-03 | 45 | 22 | 2 | M39571 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 2.31e-03 | 46 | 22 | 2 | M48243 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.31e-03 | 46 | 22 | 2 | M198 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.31e-03 | 46 | 22 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.41e-03 | 47 | 22 | 2 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.62e-03 | 49 | 22 | 2 | M618 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.83e-03 | 51 | 22 | 2 | MM14967 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.50e-03 | 199 | 22 | 3 | M7253 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 3.52e-03 | 57 | 22 | 2 | M48326 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 3.65e-03 | 58 | 22 | 2 | M29616 | |
| Pathway | PID_NOTCH_PATHWAY | 3.77e-03 | 59 | 22 | 2 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 4.02e-03 | 61 | 22 | 2 | M39540 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 4.42e-03 | 64 | 22 | 2 | M7923 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.56e-03 | 72 | 22 | 2 | M39403 | |
| Pathway | WP_AXON_GUIDANCE | 5.56e-03 | 72 | 22 | 2 | M48335 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.71e-03 | 73 | 22 | 2 | MM15906 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.87e-03 | 74 | 22 | 2 | M616 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 6.33e-03 | 1128 | 22 | 6 | M1036 | |
| Pathway | KEGG_GLYCEROPHOSPHOLIPID_METABOLISM | 6.34e-03 | 77 | 22 | 2 | M9131 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.61e-03 | 250 | 22 | 3 | M27554 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.66e-03 | 79 | 22 | 2 | M27643 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 7.16e-03 | 82 | 22 | 2 | MM15922 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 7.42e-03 | 511 | 22 | 4 | MM15330 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 7.50e-03 | 84 | 22 | 2 | M3228 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.50e-03 | 84 | 22 | 2 | M7098 | |
| Pubmed | 6.48e-08 | 52 | 26 | 4 | 26633812 | ||
| Pubmed | 1.06e-07 | 13 | 26 | 3 | 10520995 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 15242798 | ||
| Pubmed | 4.19e-07 | 20 | 26 | 3 | 15979417 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15254769 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21911304 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 27030285 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 18591437 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24703938 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14769803 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24383743 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 28537242 | ||
| Pubmed | Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. | 5.37e-07 | 2 | 26 | 2 | 15486060 | |
| Pubmed | Human umbilical cord epithelial cells express Notch ligands Delta1 and Jagged1. | 5.37e-07 | 2 | 26 | 2 | 19150223 | |
| Pubmed | Expression of Delta1 and Serrate1 (Jagged1) in the mouse inner ear. | 5.37e-07 | 2 | 26 | 2 | 10473135 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 18688026 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16307184 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 12826675 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16403414 | ||
| Pubmed | Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients. | 1.61e-06 | 3 | 26 | 2 | 38364458 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 12684674 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 1.61e-06 | 3 | 26 | 2 | 20812035 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 21393509 | ||
| Pubmed | Both Notch1 and its ligands in B cells promote antibody production. | 1.61e-06 | 3 | 26 | 2 | 28863329 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8923452 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 12482954 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 22080880 | ||
| Pubmed | Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. | 1.61e-06 | 3 | 26 | 2 | 9716576 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 30168730 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 27846321 | ||
| Pubmed | Transmission of survival signals through Delta-like 1 on activated CD4+ T cells. | 1.61e-06 | 3 | 26 | 2 | 27659682 | |
| Pubmed | JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. | 1.61e-06 | 3 | 26 | 2 | 17947672 | |
| Pubmed | Plexin B3 promotes neurite outgrowth, interacts homophilically, and interacts with Rin. | 1.61e-06 | 3 | 26 | 2 | 16122393 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 25069533 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15781650 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 29740434 | ||
| Pubmed | 1.72e-06 | 117 | 26 | 4 | 17145500 | ||
| Pubmed | 2.31e-06 | 126 | 26 | 4 | 16284245 | ||
| Pubmed | Notch ligands transduce different magnitudes of signaling critical for determination of T-cell fate. | 3.22e-06 | 4 | 26 | 2 | 20602435 | |
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 3.22e-06 | 4 | 26 | 2 | 22390640 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9315665 | ||
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 3.22e-06 | 4 | 26 | 2 | 23300864 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 10842060 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 15147296 | ||
| Pubmed | Notch ligands are substrates for protein O-fucosyltransferase-1 and Fringe. | 3.22e-06 | 4 | 26 | 2 | 12036964 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9858728 | ||
| Pubmed | Lunatic fringe-mediated Notch signaling regulates adult hippocampal neural stem cell maintenance. | 3.22e-06 | 4 | 26 | 2 | 28699891 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 5.37e-06 | 5 | 26 | 2 | 11006133 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11346656 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 9207795 | ||
| Pubmed | PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. | 5.37e-06 | 5 | 26 | 2 | 25387791 | |
| Pubmed | Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. | 5.37e-06 | 5 | 26 | 2 | 24070898 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 21602525 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 15788413 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 12183458 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11713346 | ||
| Pubmed | Notch ligands with contrasting functions: Jagged1 and Delta1 in the mouse inner ear. | 5.37e-06 | 5 | 26 | 2 | 16495313 | |
| Pubmed | Interplay between scatter factor receptors and B plexins controls invasive growth. | 5.37e-06 | 5 | 26 | 2 | 15184888 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 12175503 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 19682396 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 20554499 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 10958687 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 9272948 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19692652 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 8.05e-06 | 6 | 26 | 2 | 19603167 | |
| Pubmed | The CD46-Jagged1 interaction is critical for human TH1 immunity. | 8.05e-06 | 6 | 26 | 2 | 23086448 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19217325 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 28089369 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 31071093 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 10079256 | ||
| Pubmed | Impaired expression of Notch signaling genes in aged human skeletal muscle. | 1.13e-05 | 7 | 26 | 2 | 17301032 | |
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.13e-05 | 7 | 26 | 2 | 12846471 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 32152201 | ||
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.13e-05 | 7 | 26 | 2 | 24711412 | |
| Pubmed | Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. | 1.13e-05 | 7 | 26 | 2 | 21238454 | |
| Pubmed | 1.29e-05 | 417 | 26 | 5 | 19199708 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 15661641 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 15161092 | ||
| Pubmed | Role of the Notch ligand Delta1 in embryonic and adult mouse epidermis. | 1.50e-05 | 8 | 26 | 2 | 17960184 | |
| Pubmed | An ENU-mutagenesis screen in the mouse: identification of novel developmental gene functions. | 1.50e-05 | 8 | 26 | 2 | 21559415 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.50e-05 | 8 | 26 | 2 | 15465493 | |
| Pubmed | Dual role of laminin‑511 in regulating melanocyte migration and differentiation. | 1.50e-05 | 8 | 26 | 2 | 30273664 | |
| Pubmed | Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. | 1.50e-05 | 8 | 26 | 2 | 24647000 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 19651211 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 9858718 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 11044610 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 11118901 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 16245338 | ||
| Pubmed | Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. | 1.93e-05 | 9 | 26 | 2 | 28714968 | |
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 15574878 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 11937492 | ||
| Pubmed | Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. | 1.93e-05 | 9 | 26 | 2 | 17685488 | |
| Pubmed | Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation. | 1.93e-05 | 9 | 26 | 2 | 20727173 | |
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 1.93e-05 | 9 | 26 | 2 | 10837027 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.41e-05 | 10 | 26 | 2 | 23665443 | |
| Pubmed | Jag1-Notch cis-interaction determines cell fate segregation in pancreatic development. | 2.41e-05 | 10 | 26 | 2 | 36681690 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 34519339 | ||
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 24015274 | ||
| Pubmed | A modifier in the 129S2/SvPasCrl genome is responsible for the viability of Notch1[12f/12f] mice. | 2.41e-05 | 10 | 26 | 2 | 31590629 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 24715457 | ||
| Interaction | MFAP5 interactions | 5.93e-09 | 52 | 26 | 5 | int:MFAP5 | |
| Interaction | FBXO2 interactions | 6.56e-07 | 411 | 26 | 7 | int:FBXO2 | |
| Interaction | SLURP1 interactions | 3.31e-05 | 144 | 26 | 4 | int:SLURP1 | |
| Interaction | LGALS1 interactions | 5.83e-05 | 332 | 26 | 5 | int:LGALS1 | |
| Interaction | NOTCH2 interactions | 1.82e-04 | 423 | 26 | 5 | int:NOTCH2 | |
| Interaction | NEURL1 interactions | 2.15e-04 | 17 | 26 | 2 | int:NEURL1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 6.55e-03 | 681 | 26 | 3 | chr1p36 | |
| GeneFamily | Plexins | 4.17e-05 | 9 | 20 | 2 | 683 | |
| GeneFamily | Laminin subunits | 7.62e-05 | 12 | 20 | 2 | 626 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.18e-04 | 20 | 20 | 2 | 736 | |
| GeneFamily | Phospholipases | 9.75e-04 | 42 | 20 | 2 | 467 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.89e-03 | 394 | 20 | 3 | 471 | |
| Coexpression | NABA_MATRISOME | ADAMTS15 LAMA5 HGF EMILIN3 LAMB4 MEGF8 SEMA7A SEMA5B PLXNB2 VWA2 MUC4 MEGF10 PLXNB3 | 3.04e-12 | 1026 | 26 | 13 | M5889 |
| Coexpression | NABA_MATRISOME | ADAMTS15 LAMA5 HGF EMILIN3 MEGF8 SEMA7A SEMA5B PLXNB2 VWA2 MUC4 MEGF10 PLXNB3 | 5.76e-11 | 1008 | 26 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.15e-08 | 738 | 26 | 9 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.50e-08 | 751 | 26 | 9 | M5885 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.44e-07 | 158 | 26 | 5 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.37e-07 | 170 | 26 | 5 | M5880 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 4.09e-06 | 110 | 26 | 4 | M2396 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 5.97e-06 | 121 | 26 | 4 | MM935 | |
| Coexpression | HUTTMANN_B_CLL_POOR_SURVIVAL_UP | 7.87e-06 | 284 | 26 | 5 | M19993 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.98e-05 | 196 | 26 | 4 | M3008 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 3.98e-05 | 196 | 26 | 4 | M2445 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 4.06e-05 | 197 | 26 | 4 | MM1320 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.13e-04 | 16 | 26 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.13e-04 | 16 | 26 | 2 | MM1296 | |
| Coexpression | NABA_CORE_MATRISOME | 1.48e-04 | 275 | 26 | 4 | M5884 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 1.78e-04 | 20 | 26 | 2 | M48357 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | 1.85e-04 | 1276 | 26 | 7 | M39173 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 1.99e-04 | 115 | 26 | 3 | M45752 | |
| Coexpression | GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN | 2.37e-04 | 122 | 26 | 3 | M6861 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 3.19e-04 | 135 | 26 | 3 | M5825 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 4.09e-04 | 147 | 26 | 3 | MM3753 | |
| Coexpression | RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP | 4.17e-04 | 148 | 26 | 3 | M39016 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 4.61e-04 | 32 | 26 | 2 | M5903 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 5.33e-04 | 161 | 26 | 3 | M2121 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 5.53e-04 | 163 | 26 | 3 | M12112 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 6.91e-04 | 176 | 26 | 3 | M7725 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP | 6.91e-04 | 176 | 26 | 3 | M8881 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.21e-04 | 40 | 26 | 2 | M5887 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 7.25e-04 | 179 | 26 | 3 | M39308 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 7.95e-04 | 42 | 26 | 2 | M5895 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 8.23e-04 | 433 | 26 | 4 | M2240 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.75e-04 | 191 | 26 | 3 | MM17059 | |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP | 8.75e-04 | 191 | 26 | 3 | M4722 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 9.01e-04 | 780 | 26 | 5 | M2324 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 9.16e-04 | 194 | 26 | 3 | M2081 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BASOPHIL_UP | 9.43e-04 | 196 | 26 | 3 | M5413 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 9.43e-04 | 196 | 26 | 3 | M8683 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP | 9.43e-04 | 196 | 26 | 3 | M8714 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 9.57e-04 | 197 | 26 | 3 | M8686 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP | 9.71e-04 | 198 | 26 | 3 | M8158 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN | 9.71e-04 | 198 | 26 | 3 | M8723 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 9.85e-04 | 199 | 26 | 3 | M9410 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN | 9.85e-04 | 199 | 26 | 3 | M8721 | |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN | 1.00e-03 | 200 | 26 | 3 | M8574 | |
| Coexpression | GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN | 1.00e-03 | 200 | 26 | 3 | M5104 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_UP | 1.00e-03 | 200 | 26 | 3 | M5108 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M328 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 1.00e-03 | 200 | 26 | 3 | M7469 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN | 1.00e-03 | 200 | 26 | 3 | M4496 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN | 1.00e-03 | 200 | 26 | 3 | M4480 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN | 1.00e-03 | 200 | 26 | 3 | M4486 | |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 1.00e-03 | 200 | 26 | 3 | M8217 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M8222 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN | 1.00e-03 | 200 | 26 | 3 | M4375 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_LUNG_DN | 1.00e-03 | 200 | 26 | 3 | M4365 | |
| Coexpression | DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS | 1.04e-03 | 48 | 26 | 2 | M40200 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.04e-03 | 805 | 26 | 5 | MM1067 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.13e-03 | 209 | 26 | 3 | MM1058 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_200 | 6.16e-05 | 63 | 26 | 3 | gudmap_developingGonad_P2_testes_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 1.27e-04 | 973 | 26 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.68e-04 | 438 | 26 | 5 | GSM605850_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 2.02e-04 | 456 | 26 | 5 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 2.09e-04 | 459 | 26 | 5 | GSM777037_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_500 | 2.29e-04 | 98 | 26 | 3 | gudmap_developingGonad_e14.5_ testes_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 2.43e-04 | 19 | 26 | 2 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 2.82e-04 | 490 | 26 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-06 | 160 | 26 | 4 | 2586035a1380bc56814a6db0ca773ad835666042 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-06 | 160 | 26 | 4 | 3b5a335786165391fe983ff0585cd508733793aa | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.61e-06 | 182 | 26 | 4 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.77e-06 | 184 | 26 | 4 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 4.02e-06 | 187 | 26 | 4 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 187 | 26 | 4 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-06 | 189 | 26 | 4 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.37e-06 | 191 | 26 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.46e-06 | 192 | 26 | 4 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-06 | 197 | 26 | 4 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-06 | 197 | 26 | 4 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.04e-06 | 198 | 26 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.49e-05 | 119 | 26 | 3 | ec3af1253f03b3ec403f73243237acf08ad56789 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.82e-05 | 137 | 26 | 3 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.12e-05 | 139 | 26 | 3 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.28e-05 | 140 | 26 | 3 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.75e-05 | 143 | 26 | 3 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.75e-05 | 143 | 26 | 3 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.24e-05 | 146 | 26 | 3 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.58e-05 | 148 | 26 | 3 | d60f93311cfa718d026a0dbf61771bbbcbb79146 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.58e-05 | 148 | 26 | 3 | 44128692824ca419fface0af41099c17135933ce | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.93e-05 | 150 | 26 | 3 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 153 | 26 | 3 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-05 | 154 | 26 | 3 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-05 | 154 | 26 | 3 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 158 | 26 | 3 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 158 | 26 | 3 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 159 | 26 | 3 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 161 | 26 | 3 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 163 | 26 | 3 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 163 | 26 | 3 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.20e-04 | 166 | 26 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.23e-04 | 167 | 26 | 3 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 168 | 26 | 3 | 2163e6774eb7a3d010422e4d59be5e45b4158329 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 169 | 26 | 3 | 40b557549fe08c5dc9dba359af35993d68d1640a | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-04 | 169 | 26 | 3 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 169 | 26 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | 8066b4c02c97d00034802cff2b39799ef44cc904 | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 170 | 26 | 3 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-04 | 170 | 26 | 3 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.29e-04 | 170 | 26 | 3 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 170 | 26 | 3 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 170 | 26 | 3 | fed8e982d2ce234c59d4016432ed8941df36df27 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 170 | 26 | 3 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-04 | 172 | 26 | 3 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | 36fe66a8c0aecee7a19269be23210c0ed7abb155 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 173 | 26 | 3 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | Dendritic_Cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 173 | 26 | 3 | ddb900ef4abeabe2e59db1009efc337e35d301fe | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 174 | 26 | 3 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 1.41e-04 | 175 | 26 | 3 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 175 | 26 | 3 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.43e-04 | 176 | 26 | 3 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 176 | 26 | 3 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-04 | 176 | 26 | 3 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.46e-04 | 177 | 26 | 3 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.48e-04 | 178 | 26 | 3 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-04 | 178 | 26 | 3 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-04 | 178 | 26 | 3 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 178 | 26 | 3 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 178 | 26 | 3 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 178 | 26 | 3 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-04 | 179 | 26 | 3 | ba64bfb757d6e3be631ee95abfa24b47861f6a14 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 181 | 26 | 3 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.56e-04 | 181 | 26 | 3 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-04 | 181 | 26 | 3 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 181 | 26 | 3 | c8286a7ac8e3cc5aa7e92b043a08435294ea686f | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | f6717e97e87513384149800c9fd8dea821ab9393 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | c33b0d532822186a1e8e645500347972468718c0 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.61e-04 | 183 | 26 | 3 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.61e-04 | 183 | 26 | 3 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 183 | 26 | 3 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 184 | 26 | 3 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 1.63e-04 | 184 | 26 | 3 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.63e-04 | 184 | 26 | 3 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.63e-04 | 184 | 26 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 1.63e-04 | 184 | 26 | 3 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 184 | 26 | 3 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-04 | 184 | 26 | 3 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-04 | 184 | 26 | 3 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 184 | 26 | 3 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.66e-04 | 185 | 26 | 3 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 185 | 26 | 3 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 185 | 26 | 3 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 185 | 26 | 3 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 185 | 26 | 3 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 185 | 26 | 3 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-Epcam+|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | b18d7398279a2d42414318aeb70514fd402f5a0a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 186 | 26 | 3 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 186 | 26 | 3 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-04 | 186 | 26 | 3 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 186 | 26 | 3 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.69e-04 | 186 | 26 | 3 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 186 | 26 | 3 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 187 | 26 | 3 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-04 | 187 | 26 | 3 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| Computational | Genes in the cancer module 346. | 2.79e-04 | 17 | 16 | 2 | MODULE_346 | |
| Computational | Genes in the cancer module 408. | 3.13e-04 | 18 | 16 | 2 | MODULE_408 | |
| Computational | Genes in the cancer module 417. | 4.72e-04 | 22 | 16 | 2 | MODULE_417 | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.43e-06 | 194 | 26 | 5 | 4260_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.49e-06 | 195 | 26 | 5 | 6035_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.62e-06 | 197 | 26 | 5 | 5633_UP | |
| Drug | rebamipide | 2.65e-05 | 51 | 26 | 3 | CID000005042 | |
| Drug | VTEs | 5.61e-05 | 10 | 26 | 2 | CID000006516 | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 5610_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 6176_UP | |
| Drug | AC1L1G72 | 6.85e-05 | 11 | 26 | 2 | CID000003553 | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 5627_UP | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 5069_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 4488_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 6094_UP | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 3681_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 3737_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3909_UP | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 5067_UP | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4280_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4603_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3970_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 2302_UP | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 6816_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 6444_UP | |
| Drug | chondroitin sulfate | 9.21e-05 | 413 | 26 | 5 | CID000024766 | |
| Drug | K00077 | 1.07e-04 | 220 | 26 | 4 | CID006419759 | |
| Drug | AC1O0UVD | 1.10e-04 | 82 | 26 | 3 | CID006102706 | |
| Drug | Rgd Peptide | 1.48e-04 | 239 | 26 | 4 | CID000104802 | |
| Disease | temporal arteritis (is_marker_for) | 1.56e-05 | 7 | 26 | 2 | DOID:13375 (is_marker_for) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 1.56e-05 | 7 | 26 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | polymyositis (is_marker_for) | 4.09e-05 | 11 | 26 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 5.79e-05 | 13 | 26 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | corpus callosum volume measurement | 9.28e-05 | 100 | 26 | 3 | EFO_0010299 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 1.26e-04 | 19 | 26 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 1.55e-04 | 21 | 26 | 2 | EFO_0007908, EFO_0007938 | |
| Disease | pre-eclampsia (is_implicated_in) | 2.21e-04 | 25 | 26 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | myocardial infarction (is_marker_for) | 3.88e-04 | 33 | 26 | 2 | DOID:5844 (is_marker_for) | |
| Disease | Thrombus | 7.55e-04 | 46 | 26 | 2 | C0087086 | |
| Disease | multiple sclerosis (is_marker_for) | 8.56e-04 | 49 | 26 | 2 | DOID:2377 (is_marker_for) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.56e-04 | 49 | 26 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Thrombosis | 8.56e-04 | 49 | 26 | 2 | C0040053 | |
| Disease | Schizophrenia | 9.25e-04 | 883 | 26 | 5 | C0036341 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.46e-03 | 64 | 26 | 2 | DOID:4947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRLCQATYEGEWCRG | 351 | Q60I27 | |
| PDGYTCCRLQSGAWG | 291 | P28799 | |
| DNRQGWACCPYRQGV | 536 | P28799 | |
| KWDPYGPCSRTCGGG | 521 | Q8TE58 | |
| WLGKYRNEECDPGGC | 586 | Q4KMQ2 | |
| TCYCSPGWKGARCDQ | 816 | Q96KG7 | |
| RGGVCCSYGPWGEFR | 4616 | Q99102 | |
| RAANPDYRCAWCGGQ | 771 | O15031 | |
| GCLWCADGQPACRYG | 806 | Q9ULL4 | |
| CRKRGPGFCDECQDW | 1171 | Q7Z7M0 | |
| YCRNPRGEEGGPWCF | 176 | P14210 | |
| RDCSRCATGYWGFPN | 1466 | O15230 | |
| CYCGWGGRGTPKDGT | 46 | P39877 | |
| GWRRCSCAPGYKLGD | 156 | P04070 | |
| GECKCRVGWQGRYCD | 241 | O00548 | |
| CDRCADGYWNLVPGR | 1061 | A4D0S4 | |
| AEYRQCRWGPKCPGT | 81 | Q9NT22 | |
| SLCGPGCYRRWNADG | 81 | Q96HA4 | |
| KLPGDCRCQYGWQGL | 246 | P78504 | |
| PGLNCCGQGRACYRW | 236 | Q13393 | |
| NGSYRCKCRDGWEGP | 731 | Q5GFL6 | |
| SRDPYCGWDQGRCIS | 506 | O75326 | |
| SQGACLGARDPYCGW | 561 | Q9P283 | |
| TRKYWCRQGARGGCI | 51 | P01833 | |
| CGDCKFGWTGPNCER | 106 | P40126 | |
| RPGWYCALSKQEGCR | 121 | P20333 | |
| GYNIWTGGPDACLRC | 431 | Q9H808 |